Loading company…
MiLaboratories develops software for analyzing T-cell and B-cell receptor repertoires.
Founded in 2021 in California, MiLaboratories develops MiXCR, software for analyzing T-cell and B-cell receptor sequencing data. Its tools support experiment planning, sample preparation, and analysis for research into vaccines, cancer, antibodies, and autoimmune diseases. The company raised USD 2.3 million in Seed funding in February 2022, co-led by Acrobator Ventures and Speedinvest, to develop its software and expand its Latvia office.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in